Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea · Delayed Price · Currency is KRW
5,640.00
+100.00 (1.81%)
At close: Aug 21, 2025
Sinsin Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|
Aug '25 Aug 20, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
---|
| 86,472 | 82,376 | 94,664 | 84,651 | 97,850 | 138,658 | |
| 7.32% | -12.98% | 11.83% | -13.49% | -29.43% | 34.02% | |
| 132,744 | 122,361 | 135,899 | 130,024 | 145,574 | 183,301 | |
| 5700.00 | 5430.00 | 6170.92 | 5463.41 | 6258.03 | 8867.97 | |
| 20.77 | 16.85 | 20.23 | 19.18 | - | 382.34 | |
| 0.81 | 0.77 | 0.92 | 0.92 | 1.32 | 2.07 | |
| 1.27 | 1.26 | 1.53 | 1.42 | 1.79 | 2.47 | |
| 1.28 | 1.26 | 1.53 | 1.43 | 1.80 | 2.49 | |
| 36.48 | 18.56 | - | 18.59 | - | - | |
| 19.05 | 13.86 | 24.09 | 15.50 | 4220.66 | 74.34 | |
| 1.24 | 1.15 | 1.33 | 1.41 | 1.97 | 2.73 | |
| 12.29 | 10.97 | 13.67 | 14.16 | 62.51 | - | |
| 20.37 | 17.76 | 22.64 | 23.96 | - | - | |
| 55.99 | 27.57 | - | 28.56 | - | - | |
| 0.70 | 0.70 | 0.72 | 0.73 | 0.84 | 0.81 | |
| 4.38 | 4.09 | 4.48 | 4.73 | 19.85 | - | |
| 19.95 | 10.27 | - | 9.55 | - | - | |
| 0.81 | 0.84 | 0.84 | 0.78 | 0.64 | 0.54 | |
| 4.03 | 4.34 | 4.60 | 4.98 | 4.60 | 3.85 | |
| 0.58 | 0.56 | 0.59 | 0.71 | 0.76 | 0.77 | |
| 0.89 | 0.87 | 0.91 | 1.06 | 1.08 | 1.15 | |
| 6.28% | 7.54% | 7.64% | 7.62% | -2.61% | 0.36% | |
| 3.09% | 3.39% | 3.06% | 2.88% | -0.72% | -2.11% | |
| 3.63% | 3.96% | 3.58% | 3.32% | -0.83% | -2.46% | |
Return on Capital Employed (ROCE) | 9.20% | 9.80% | 8.30% | 6.90% | - | - | |
| 4.82% | 5.93% | 4.94% | 5.21% | -1.51% | 0.26% | |
| 2.74% | 5.39% | -1.14% | 5.38% | -2.72% | -7.29% | |
| 1.05% | 1.10% | - | - | - | - | |
| 21.86% | 18.62% | 16.21% | - | - | 117.13% | |
| 0.29% | - | - | - | - | - | |
| 1.34% | 1.10% | - | - | - | - | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.